Daniel P. Finke - 04 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP/Pres, Health Care Benefits
Signature
/s/ Daniel P. Finke
Issuer symbol
CVS
Transactions as of
04 Apr 2022
Net transactions value
-$3,676,568
Form type
4
Filing time
06 Apr 2022, 17:02:51 UTC
Previous filing
05 Apr 2022
Next filing
05 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $875,765 +16,161 +32% $54.19 66,284 04 Apr 2022 Direct
transaction CVS Common Stock Sale $1,618,201 -16,161 -24% $100.13 50,123 04 Apr 2022 Direct F1
transaction CVS Common Stock Options Exercise $1,584,864 +27,166 +54% $58.34 77,289 04 Apr 2022 Direct
transaction CVS Common Stock Sale $2,720,132 -27,166 -35% $100.13 50,123 04 Apr 2022 Direct F1
transaction CVS Common Stock Sale $1,204,764 -12,032 -24% $100.13 38,091 04 Apr 2022 Direct F1
transaction CVS Common Stock Sale $594,100 -5,941 -16% $100.00 32,150 05 Apr 2022 Direct F1
holding CVS Common Stock (pep) 3,098 04 Apr 2022 Direct
holding CVS Common Stock (restricted) 15,904 04 Apr 2022 Direct
holding CVS Stock Unit (deferred) 3,098 04 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -16,161 -50% $0.000000 16,161 04 Apr 2022 Common Stock 16,161 $54.19 Direct F2
transaction CVS Stock Option Options Exercise $0 -27,166 -50% $0.000000 27,166 04 Apr 2022 Common Stock 27,166 $58.34 Direct F3
holding CVS Stock Option 82,066 04 Apr 2022 Common Stock 82,066 $74.30 Direct F4
holding CVS Stock Option 28,640 04 Apr 2022 Common Stock 28,640 $52.37 Direct F5
holding CVS Stock Option 51,975 04 Apr 2022 Common Stock 51,975 $101.09 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Option became exercisable in four equal annual installments, beginning on 4/1/2020.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F4 Option becomes exercisable in four equal installments, commencing 4/1/2022.
F5 Option becomes exercisable in three equal installments, commencing 5/31/2022.
F6 Option becomes exercisable in four equal installments, commencing 4/1/2023.